Position in PBH
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$15,039,940
+$358,769 QoQ
Shares Held
253,753
+6.6% QoQ
Ownership
0.536%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
20 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in PBH Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026NATIXIS ADVISORS, LLC holds $166,492,947 across 17 Drug Manufacturers - Specialty & Generic names. PBH ranks #3 (9.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HLN |
Haleon plc
|
9,198,299 | $92,074,972 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
565,862 | $17,043,763 | |
| 3 | PBH |
Prestige Consumer Healthcare Inc.
This page
|
253,753 | $15,039,940 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
15,249 | $9,042,352 | |
| 5 | ZTS |
Zoetis Inc.
|
65,865 | $7,785,901 | |
| 6 | TAK |
Takeda Pharmaceutical Co Ltd
|
324,034 | $6,001,109 | |
| 7 | NBIX |
Neurocrine Biosciences Inc
|
43,597 | $5,743,468 | |
| 8 | VTRS |
Viatris Inc
|
234,320 | $3,165,663 |
All Filings in PBH
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $15,039,940 | 253,753 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $14,681,171 | 237,983 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $13,515,777 | 216,599 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $22,996,480 | 287,996 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $17,897,750 | 208,186 | Shares | Defined | 2025-05-08 | |
| 2024-12-31 | $16,340,020 | 209,246 | Shares | Defined | 2025-02-10 | |
| 2024-09-30 | $1,051,290 | 14,581 | Shares | Defined | 2024-11-06 | |
| 2024-06-30 | $901,246 | 13,090 | Shares | Defined | 2024-08-01 | |
| 2024-03-31 | $1,012,719 | 13,957 | Shares | Defined | 2024-04-25 | |
| 2023-12-31 | $763,903 | 12,478 | Shares | Defined | 2024-02-06 | |
| 2023-09-30 | $662,031 | 11,576 | Shares | Defined | 2023-11-13 | |
| 2023-03-31 | $948,656 | 15,147 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $839,153 | 13,405 | Shares | Defined | 2023-01-27 | |
| 2022-06-30 | $879,883 | 14,964 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $554,546 | 10,475 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $684,313 | 11,283 | Shares | Defined | 2022-02-08 | |
| 2020-12-31 | $3,098,827 | 88,868 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $3,115,767 | 85,551 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $3,277,110 | 87,250 | Shares | Defined | 2020-08-11 | |
| 2020-03-31 | $3,807,127 | 103,793 | Shares | Defined | 2020-04-27 | |
| No filing history on record for this holder in this stock. | ||||||